News
The company posted an adjusted net profit in its latest reported quarter, but there wasn't much else producing a high for investors.
StockStory.org on MSN3d
Tilray (NASDAQ:TLRY) Reports Sales Below Analyst Estimates In Q2 EarningsCannabis company Tilray Brands (NASDAQ:TLRY) in Q2 CY2025, with sales falling 2.3% year on year to $224.5 million. Its GAAP ...
Shares of the cannabis producer have been rallying, but they are still nowhere near the levels they were at a few years ago.
Shares of Tilray Brands (NASDAQ: TLRY) tumbled 14.2% through 12:15 p.m. ET after the company reported mixed fiscal Q4 2025 ...
17d
MarketBeat on MSNTilray Shares Blazing: What's Behind the 55% Rally This Month?Tilray Brands Inc. (NASDAQ: TLRY), once a leading light in the legal cannabis industry with shares trading as high as nearly $150, has seen its stock price almost entirely collapse in recent years. A ...
StockStory.org on MSN5d
Tilray (TLRY) Reports Q2: Everything You Need To Know Ahead Of EarningsCannabis company Tilray Brands (NASDAQ:TLRY) will be announcing earnings results this Monday afternoon. Here’s what you need ...
Shares of Tilray Brands (NASDAQ:TLRY) fell sharply on Tuesday, sending its cannabis rivals lower, after the Canadian Licensed ...
Tilray Brands Inc (NASDAQ: TLRY) soared more than 15% today as retail investors continued to grow their positions in the ...
StockStory.org on MSN16d
Tilray (TLRY) Stock Is Up, What You Need To KnowWhat Happened? Shares of cannabis company Tilray Brands (NASDAQ:TLRY) jumped 3.5% in the morning session on continued momentum that saw the stock rise significantly in July. The stock's upward ...
StockStory.org on MSN14d
Tilray (TLRY) Stock Trades Up, Here Is WhyWhat Happened? Shares of cannabis company Tilray Brands (NASDAQ:TLRY) jumped 3.3% in the afternoon session after President ...
When Tilray Brands (NASDAQ:TLRY) reports fourth quarter earnings on Monday, Wall Street expects the firm to post EPS of -$0.03, while revenue is expected to increase 1.5% to $233.29 million during the ...
Roth Capital Markets analyst Bill Kirk maintained a “Neutral” rating and lowered his 12-month price target to $0.60 from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results